The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-To-Severely Active Ulcerative Colitis

AuthID
 P-00Y-1PA
9
Author(s)
Siegmund, B
·
Sands, BE
·
Samaan, K
·
Li, XY
·
Morris, N
·
D'Haens, G
Document Type
Abstract
Year published
2022
Published
in AMERICAN JOURNAL OF GASTROENTEROLOGY, ISSN: 0002-9270
Volume: 117, Issue: 10, Pages: S543-S544 (2)
Indexing
Wos®
Publication Identifiers
Wos: WOS:000897916001361
Source Identifiers
ISSN: 0002-9270
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service